Cargando…

Developments in the management of psychosis: key evidence from 2022

ABSTRACT: The field of treatment and understanding in psychosis is evolving at an unprecedented pace with advances in neuroscience. It takes time before research findings are translated to clinical practice. Daunting as it is, clinicians need to keep up with findings which change our practice straig...

Descripción completa

Detalles Bibliográficos
Autor principal: Chakraborty, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377441/
http://dx.doi.org/10.1192/j.eurpsy.2023.38
_version_ 1785079518582538240
author Chakraborty, N.
author_facet Chakraborty, N.
author_sort Chakraborty, N.
collection PubMed
description ABSTRACT: The field of treatment and understanding in psychosis is evolving at an unprecedented pace with advances in neuroscience. It takes time before research findings are translated to clinical practice. Daunting as it is, clinicians need to keep up with findings which change our practice straightaway (new medication), findings which suggest that changes are expected in future (new theories about how illness develops and can be predicted) and findings which remind us of continuing practice and the evidence behind them (long term follow-up studies which give no big surprises but consolidate existing knowledge). In a snap shot, I bring to you a range of five papers published in 2022 which enrich our understanding of psychosis, its development and treatment. DISCLOSURE OF INTEREST: None Declared
format Online
Article
Text
id pubmed-10377441
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-103774412023-07-29 Developments in the management of psychosis: key evidence from 2022 Chakraborty, N. Eur Psychiatry Abstract ABSTRACT: The field of treatment and understanding in psychosis is evolving at an unprecedented pace with advances in neuroscience. It takes time before research findings are translated to clinical practice. Daunting as it is, clinicians need to keep up with findings which change our practice straightaway (new medication), findings which suggest that changes are expected in future (new theories about how illness develops and can be predicted) and findings which remind us of continuing practice and the evidence behind them (long term follow-up studies which give no big surprises but consolidate existing knowledge). In a snap shot, I bring to you a range of five papers published in 2022 which enrich our understanding of psychosis, its development and treatment. DISCLOSURE OF INTEREST: None Declared Cambridge University Press 2023-07-19 /pmc/articles/PMC10377441/ http://dx.doi.org/10.1192/j.eurpsy.2023.38 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Chakraborty, N.
Developments in the management of psychosis: key evidence from 2022
title Developments in the management of psychosis: key evidence from 2022
title_full Developments in the management of psychosis: key evidence from 2022
title_fullStr Developments in the management of psychosis: key evidence from 2022
title_full_unstemmed Developments in the management of psychosis: key evidence from 2022
title_short Developments in the management of psychosis: key evidence from 2022
title_sort developments in the management of psychosis: key evidence from 2022
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377441/
http://dx.doi.org/10.1192/j.eurpsy.2023.38
work_keys_str_mv AT chakrabortyn developmentsinthemanagementofpsychosiskeyevidencefrom2022